Apolipoprotein (APOE) 4-related differences in memory performance have been detected before age 65. The hippocampus and the surrounding medial temporal lobe (MTL) structures are the first site affected by Alzheimer's disease (AD) and the MTL is the seat of episodic memory, including visuo-spatial memory. While reports of APOE 4-related differences in these brain structures are not consistent in either crosssectional or longitudinal structural and functional magnetic resonance imaging (fMRI) studies, there is increasing evidence that brain activity at baseline (defined as activity during fixation or rest) may differ in APOE 4 carriers compared to non-carriers. In this fMRI study, cognitively normal APOE 4 carriers and non-carriers engaged in a perspective-dependent spatial learning task (Shelton & Gabrieli, 2002) previously shown to activate MTL structures in older participants (Borghesani et al., 2008). A low-level, visually engaging dot-control task was used for comparison, in addition to fixation. APOE 4 carriers showed less activation than non-carriers in the hippocampus proper during encoding. Specifically, when spatial encoding was contrasted against the dot-control task, encoding-related activation was significantly lower in carriers than non-carriers. By contrast, no 4-related differences in the hippocampus were found when spatial encoding was compared with fixation. Lower activation, however, was not global since encodingrelated activation in early visual cortex (left lingual gyrus) was not different between APOE 4 carriers and non-carriers. The present data document APOE 4-related differences in the hippocampus proper during encoding and underscore the role of low-level control contrasts for complex encoding tasks. These results have implications for fMRI studies that investigate the default-mode network (DMN) in middleaged to older APOE 4 carriers to help evaluate AD risk in this otherwise cognitively normal population.
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Introduction
Carriers of apolipoprotein (APOE) 4 are at an increased risk of developing late onset Alzheimer's disease (AD) (Corder et al., 1993; Saunders et al., 1993; Tanzi & Bertram, 2001 ). Carrying at least one 4 allele is a predictor of clinical progression from Mild Cognitive Impairment (MCI) to AD (de Leon et al., 2007; DeCarli et al., 2001; Landau et al., in press; Petersen et al., 1995) . In cognitively normal populations, APOE 4-related differences in neuropsychological task performance have been detected before age 65 (Adamson et al., 2010; Blair et al., 2005; Caselli et al., 2009; Kozauer, Mielke, Chan, Rebok, & Lyketsos, 2008; ) , although differences are typically modest (Small, Rosnick, Fratiglioni, & Backman, 2004; Wisdom, Callahan, & Hawkins, 2011) . The medial temporal lobe (MTL) is the seat of episodic memory (Eichenbaum, 2000; Schacter & Wagner, 1999; Squire, Stark, & Clark, 2004) , including visuo-spatial memory (Burgess, Maguire, & O'Keefe, 2002) , and the first site affected by AD (Braak & Braak, 1997) . However, reports of APOE 4-related differences in brain structure, particularly in the MTL, are not consistent (Wierenga & Bondi, 2007) . This is especially the case in crosssectional studies, which have alternately revealed smaller and no difference in hippocampal volumes in APOE 4 carriers compared to non-carriers (reviewed in Adamson et al., 2010) . While it is possible that the impact of APOE 4 on hippocampal volume changes over time will turn out to be larger or more consistent than singletime point assessments, more timely methods of assessing early indications of AD pathology are needed. Functional magnetic resonance imaging (fMRI) studies frequently focus on MTL subregions
